Table 1.

Summary of CFIR Constructs Identified in Each Theme.

Themes identified	CFIR constructs
Current perceptions and beliefs regarding the use of SGLT2 inhibitors in BC, Canada.
SGLT2 inhibitors are underutilized	Tension for change, cost, desired sources
SGLT2 inhibitors are efficacious	Evidence strength and quality, Knowledge and beliefs about the intervention
SGLT2 inhibitors have distinct advantages over other agents	Relative advantage
Clinician factors
Clinicians identified knowledge translation is a key barrier	Peer pressure, access to knowledge and information, existing sources, desired sources, and knowledge translation
Clinicians were using SGLT2 inhibitors as part of their routine clinical practice	Individual stage of change
All clinicians need to play a role in prescribing SGLT2 inhibitors	Tension for change, patient needs and resources, knowledge translation, and individual identification with organization
Clinicians varied in their knowledge of and comfort prescribing SGLT2 inhibitors	Implementation climate, knowledge translation, and self-efficacy
Clinicians are influenced by their colleagues’ use of SGLT2 inhibitors	Peer pressure
Clinicians are interested and enthusiastic about learning	Implementation climate, learning climate
There is some caution with new therapies in general	Implementation climate
Therapeutic inertia plays a substantial role	Implementation climate, compatibility
Patient factors from a clinician’s perspective
SGLT2 inhibitors are sometimes intolerable due to adverse events	Complexity
Pill burden is an important issue	Complexity, design quality and packaging
Patients were enthusiastic about potential benefits	Complexity, relative advantage
Individualized approach to patient selection and use of SGLT2 inhibitors is required	Complexity, external policy and incentives
Patient retention of information is an issue	Complexity
Some patients prefer not to take any medications	Patient preference
Medication factors
Concerning adverse events	Complexity
Clinicians were comfortable managing adverse events	Complexity
Clinicians prioritized different potential adverse events when discussing them with their patients	Complexity
Health care system factors
Cost and reimbursement administration is a barrier	Cost, external policies and incentives
Audit of evidence-based care delivery is not routinely performed	External policies and incentives, goals and feedback, organizational incentives and rewards

Note. CFIR = Consolidated Framework for Implementation Research; SGLT2 = sodium-glucose cotransporter-2; BC = British Columbia.